Melanoma: New Insights and New Therapies
Authors:
Open Access
- 1 March 2012
- journal article
- review article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 132 (3) , 854-863
Abstract
No abstract availableKeywords
This publication has 93 references indexed in Scilit:
- KIT as a Therapeutic Target in Metastatic MelanomaJAMA, 2011
- Hallmarks of Cancer: The Next GenerationCell, 2011
- Acquired Resistance to BRAF Inhibitors Mediated by a RAF Kinase Switch in Melanoma Can Be Overcome by Cotargeting MEK and IGF-1R/PI3KCancer Cell, 2010
- COT drives resistance to RAF inhibition through MAP kinase pathway reactivationNature, 2010
- Melanomas acquire resistance to B-RAF(V600E) inhibition by RTK or N-RAS upregulationNature, 2010
- Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAFCell, 2010
- BrafV600E cooperates with Pten loss to induce metastatic melanomaNature Genetics, 2009
- Phase 2 trial of carboplatin, weekly paclitaxel, and biweekly bevacizumab in patients with unresectable stage IV melanomaCancer, 2008
- Frequent somatic mutations of GNAQ in uveal melanoma and blue naeviNature, 2008
- Mutations of the BRAF gene in human cancerNature, 2002